Literature DB >> 11113183

Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice.

S D Dufresne1, C Bjørbaek, K El-Haschimi, Y Zhao, W G Aschenbach, D E Moller, L J Goodyear.   

Abstract

The p90 ribosomal S6 kinase (RSK), a cytosolic substrate for the extracellular signal-regulated kinase (ERK), is involved in transcriptional regulation, and one isoform (RSK2) has been implicated in the activation of glycogen synthase by insulin. To determine RSK2 function in vivo, mice lacking a functional rsk2 gene were generated and studied in response to insulin and exercise, two potent stimulators of the ERK cascade in skeletal muscle. RSK2 knockout (KO) mice weigh 10% less and are 14% shorter than wild-type (WT) mice. They also have impaired learning and coordination. Hindlimb skeletal muscles were obtained from mice 10, 15, or 30 min after insulin injection or immediately after strenuous treadmill exercise for 60 min. While insulin and exercise significantly increased ERK phosphorylation in skeletal muscle from both WT and KO mice, the increases were twofold greater in the KO animals. This occurred despite 27% lower ERK2 protein expression in skeletal muscle of KO mice. KO mice had 18% less muscle glycogen in the fasted basal state, and insulin increased glycogen synthase activity more in KO than WT mice. The enhanced insulin-stimulated increases in ERK and glycogen synthase activities in KO mice were not associated with higher insulin receptor or with IRS1 tyrosine phosphorylation or with IRS1 binding to phosphatidylinositol 3-kinase. However, insulin-stimulated serine phosphorylation of Akt was significantly higher in the KO animals. c-fos mRNA was increased similarly in muscle from WT and KO mice in response to insulin (2. 5-fold) and exercise (15-fold). In conclusion, RSK2 likely plays a major role in feedback inhibition of the ERK pathway in skeletal muscle. Furthermore, RSK2 is not required for activation of muscle glycogen synthase by insulin but may indirectly modulate muscle glycogen synthase activity and/or glycogen content by other mechanisms, possibly through regulation of Akt. RSK2 knockout mice may be a good animal model for the study of Coffin-Lowry syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11113183      PMCID: PMC88782          DOI: 10.1128/MCB.21.1.81-87.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB.

Authors:  P C van Weeren; K M de Bruyn; A M de Vries-Smits; J van Lint; B M Burgering
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

2.  Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo.

Authors:  J A Smith; C E Poteet-Smith; K Malarkey; T W Sturgill
Journal:  J Biol Chem       Date:  1999-01-29       Impact factor: 5.157

3.  Exercise stimulates the mitogen-activated protein kinase pathway in human skeletal muscle.

Authors:  D Aronson; M A Violan; S D Dufresne; D Zangen; R A Fielding; L J Goodyear
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

4.  A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose.

Authors:  J A Thomas; K K Schlender; J Larner
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

5.  Generation of constitutively active p90 ribosomal S6 kinase in vivo. Implications for the mitogen-activated protein kinase-activated protein kinase family.

Authors:  C E Poteet-Smith; J A Smith; D A Lannigan; T A Freed; T W Sturgill
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

6.  Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3.

Authors:  P Sassone-Corsi; C A Mizzen; P Cheung; C Crosio; L Monaco; S Jacquot; A Hanauer; C D Allis
Journal:  Science       Date:  1999-08-06       Impact factor: 47.728

7.  A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1.

Authors:  M Frödin; C J Jensen; K Merienne; S Gammeltoft
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

8.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.

Authors:  D R Alessi; S R James; C P Downes; A B Holmes; P R Gaffney; C B Reese; P Cohen
Journal:  Curr Biol       Date:  1997-04-01       Impact factor: 10.834

9.  Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK.

Authors:  K N Dalby; N Morrice; F B Caudwell; J Avruch; P Cohen
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

10.  Exercise stimulates c-Jun NH2 kinase activity and c-Jun transcriptional activity in human skeletal muscle.

Authors:  D Aronson; M D Boppart; S D Dufresne; R A Fielding; L J Goodyear
Journal:  Biochem Biophys Res Commun       Date:  1998-10-09       Impact factor: 3.575

View more
  44 in total

Review 1.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

2.  Splicing of mouse p53 pre-mRNA does not always follow the "first come, first served" principle and may be influenced by cisplatin treatment and serum starvation.

Authors:  Min Yang; Jack Wu; Si-Hung Wu; An-Ding Bi; D Joshua Liao
Journal:  Mol Biol Rep       Date:  2012-06-28       Impact factor: 2.316

3.  p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling.

Authors:  Douglas J Sheffler; Wesley K Kroeze; Bonnie G Garcia; Ariel Y Deutch; Sandra J Hufeisen; Patrick Leahy; Jens C Brüning; Bryan L Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-10       Impact factor: 11.205

4.  Mechanism of sustained activation of ribosomal S6 kinase (RSK) and ERK by kaposi sarcoma-associated herpesvirus ORF45: multiprotein complexes retain active phosphorylated ERK AND RSK and protect them from dephosphorylation.

Authors:  Ersheng Kuang; Fayi Wu; Fanxiu Zhu
Journal:  J Biol Chem       Date:  2009-03-20       Impact factor: 5.157

5.  Essential role of RSK2 in c-Fos-dependent osteosarcoma development.

Authors:  Jean-Pierre David; Denis Mehic; Latifa Bakiri; Arndt F Schilling; Vice Mandic; Matthias Priemel; Maria Helena Idarraga; Markus O Reschke; Oskar Hoffmann; Michael Amling; Erwin F Wagner
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

6.  RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth.

Authors:  Ke Yao; Cong Peng; Yuwen Zhang; Tatyana A Zykova; Mee-Hyun Lee; Sung-Young Lee; Enyu Rao; Hanyong Chen; Joohyun Ryu; Lei Wang; Yi Zhang; Ge Gao; Wei He; Wei-Ya Ma; Kangdong Liu; Ann M Bode; Ziming Dong; Bing Li; Zigang Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-13       Impact factor: 11.205

7.  RSK2 signaling in medial habenula contributes to acute morphine analgesia.

Authors:  Emmanuel Darcq; Katia Befort; Pascale Koebel; Solange Pannetier; Megan K Mahoney; Claire Gaveriaux-Ruff; André Hanauer; Brigitte L Kieffer
Journal:  Neuropsychopharmacology       Date:  2012-01-04       Impact factor: 7.853

8.  RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia.

Authors:  M-A Hospital; A Jacquel; F Mazed; E Saland; C Larrue; J Mondesir; R Birsen; A S Green; M Lambert; P Sujobert; E-F Gautier; V Salnot; M Le Gall; J Decroocq; L Poulain; N Jacque; M Fontenay; O Kosmider; C Récher; P Auberger; P Mayeux; D Bouscary; J-E Sarry; J Tamburini
Journal:  Leukemia       Date:  2017-09-15       Impact factor: 11.528

9.  Protein profiles associated with context fear conditioning and their modulation by memantine.

Authors:  Md Mahiuddin Ahmed; A Ranjitha Dhanasekaran; Aaron Block; Suhong Tong; Alberto C S Costa; Katheleen J Gardiner
Journal:  Mol Cell Proteomics       Date:  2014-01-27       Impact factor: 5.911

Review 10.  Coffin-Lowry syndrome.

Authors:  Patricia Marques Pereira; Anne Schneider; Solange Pannetier; Delphine Heron; André Hanauer
Journal:  Eur J Hum Genet       Date:  2009-11-04       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.